BIOLASE INC (BIOL) Stock Analyst Ratings
NASDAQ:BIOL - Nasdaq - US0909117022 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to BIOL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.99. This target is 1441.86% above the current price.
BIOL was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about BIOL.
In the previous month the buy percentage consensus was at a similar level.
BIOL was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-02 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-09-03 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-08-12 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-05-14 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-04-01 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-03-22 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2023-05-31 | Lake Street | Maintains | Buy -> Buy |
| 2023-03-29 | Benchmark | Reiterate | Speculative Buy |
| 2023-03-29 | Maxim Group | Maintains | Buy |
| 2022-05-20 | Lake Street | Initiate | Buy |